Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study

1. Lataillade, M.
2. Lalezari, J.P.
3. Kozal, M.
4. Aberg, J.A.
5. Pialoux, G.
6. Cahn, P.
7. Thompson, M.
8. Molina, J.-M.
9. Moreno, S.
10. Grinsztejn, B.
11. Diaz, R.S.
12. Castagna, A.
13. Kumar, P.N.
14. Latiff, G.H.
15. De Jesus, E.
16. Wang, M.
17. Chabria, S.
18. Gartland, M.
19. Pierce, A.
20. Ackerman, P.
21. Llamoso, C.